Laurence Rulleau
President chez Find Therapeutics
Postes actifs de Laurence Rulleau
Sociétés | Poste | Début | Fin |
---|---|---|---|
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | - | - |
adMare Bioinnovations
adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | - | - |
CTI Capital, Inc.
CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Private Equity Investor | 01/11/2014 | - |
Find Therapeutics
Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Directeur/Membre du Conseil | - | - |
President | - | - | |
PreciThera, Inc.
PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Laurence Rulleau
Anciens postes connus de Laurence Rulleau
Sociétés | Poste | Début | Fin |
---|---|---|---|
Blackmont Capital Securities
Blackmont Capital Securities Investment Banks/BrokersFinance Blackmont Capital Securities is the broker subsidiary of Blackmont Capital, Inc. They focus on sectors such as energy, metals and minerals, biotechnology and health services, technology and special situations, business trusts and industrials, consumer staples, real estate and hospitality and financial services. Blackmont screens for emerging influences, shifts in market dynamics and changes in corporate fundamentals to identify immediate growth opportunities with the best risk-reward profile | Analyst-Equity | 02/10/2007 | 02/10/2007 |
Neomed Institute
Neomed Institute Pharmaceuticals: OtherHealth Technology Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada. | Directeur/Membre du Conseil | - | - |
Formation de Laurence Rulleau
University of Montréal | Doctorate Degree |
Université du Québec à Montréal | Graduate Degree |
Statistiques
Internationale
Canada | 10 |
Opérationnelle
Director/Board Member | 5 |
Analyst-Equity | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Finance | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 7 |
---|---|
Blackmont Capital Securities
Blackmont Capital Securities Investment Banks/BrokersFinance Blackmont Capital Securities is the broker subsidiary of Blackmont Capital, Inc. They focus on sectors such as energy, metals and minerals, biotechnology and health services, technology and special situations, business trusts and industrials, consumer staples, real estate and hospitality and financial services. Blackmont screens for emerging influences, shifts in market dynamics and changes in corporate fundamentals to identify immediate growth opportunities with the best risk-reward profile | Finance |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
Neomed Institute
Neomed Institute Pharmaceuticals: OtherHealth Technology Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada. | Health Technology |
adMare Bioinnovations
adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | |
CTI Capital, Inc.
CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Finance |
Find Therapeutics
Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
PreciThera, Inc.
PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Health Technology |
- Bourse
- Insiders
- Laurence Rulleau
- Expérience